BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34692731)

  • 1. Association of Cytomegalovirus Infection With Anti-MDA5 Antibody-Positive Dermatomyositis: A Prospective Cohort Study.
    Huang L; Zhu W; Ye Y; Wu X; Yan Q; Wang Z; Lin Y; Chen S
    Front Med (Lausanne); 2021; 8():740154. PubMed ID: 34692731
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis.
    Jin Q; Lin S; Chen X; Xu Y; Tian X; He L; Jiang W; Chen F; Shu X; Lu X; Peng Q; Wang G
    Semin Arthritis Rheum; 2024 Apr; 65():152352. PubMed ID: 38185078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center.
    Huang L; Fu Q; Ye Y; Lin Y; Yan Q; Chen S
    Arthritis Res Ther; 2021 Sep; 23(1):232. PubMed ID: 34481528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of exhausted CD8+ T cells associates with increased pulmonary fungal infection risk in anti-melanoma differentiation associated gene 5 dermatomyositis.
    Xu YT; Cao ZY; Lin S; Shu XM; Lu X; Wang GC; Peng QL
    Clin Exp Rheumatol; 2024 Feb; 42(2):237-245. PubMed ID: 38153165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in cell counts and alteration of phenotype characterize peripheral NK cells of patients with anti-MDA5-positive dermatomyositis.
    Lin S; Zhang Y; Cao Z; Xu Y; Jin Q; Chen X; Shu X; Lu X; Wang G; Peng Q
    Clin Chim Acta; 2023 Mar; 543():117321. PubMed ID: 37019328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis.
    Zhang P; Li M; Zhang Y; Lian C; Sun J; He Y; Hu W; Wang L; Li T; Liu S; Zhang Y
    Clin Rheumatol; 2023 Aug; 42(8):2145-2154. PubMed ID: 37160775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis.
    Gui X; Ma M; Ding J; Shi S; Xin X; Qiu X; Zhang Y; Qiu Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
    Rheumatology (Oxford); 2021 Aug; 60(8):3913-3922. PubMed ID: 33501503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody.
    Jiang L; Wang Y; Peng Q; Shu X; Wang G; Wu X
    Clin Rheumatol; 2019 Jun; 38(6):1655-1663. PubMed ID: 30739212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Value of
    Liang J; Cao H; Wu B; Liu Y; He Y; Xu B; Sun Y; Ye B; Lin J
    Front Immunol; 2021; 12():745211. PubMed ID: 34867971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fever, Cutaneous Ulcers, and Arthritis Define the MDA5 Phenotype in Indian Patients with Idiopathic Inflammatory Myositis.
    Devarasetti P; Mohammad I; Desai A; Rajasekhar L
    Mediterr J Rheumatol; 2022 Dec; 33(4):413-420. PubMed ID: 37034362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease.
    Matsushita T; Kobayashi T; Kano M; Hamaguchi Y; Takehara K
    J Dermatol; 2019 Dec; 46(12):1190-1196. PubMed ID: 31631384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
    Matsuda KM; Yoshizaki A; Kuzumi A; Fukasawa T; Ebata S; Yoshizaki-Ogawa A; Sato S
    J Dermatol; 2020 May; 47(5):483-489. PubMed ID: 32096271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: Diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic.
    Gupta P; Kharbanda R; Lawrence A; Gupta L
    Egypt Rheumatol; 2021 Oct; 43(4):271-274. PubMed ID: 36536808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
    Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
    Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
    Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
    PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating TFH cells is correlated with disease activity in anti-MDA5 antibody positive idiopathic inflammatory myopathies.
    Zhou M; Li M; Guo C; Wang S; Li X; Zhao S; Zhang H; Yang N
    Clin Exp Rheumatol; 2021; 39(4):804-810. PubMed ID: 32896262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Matrix Prediction Model for the 6-Month Mortality Risk in Patients With Anti-Melanoma Differentiation-Associated Protein-5-Positive Dermatomyositis.
    Ouyang ZM; Lin JZ; Tang AJ; Yang ZH; Yang LJ; Wei XN; Li QH; Liang JJ; Zheng DH; Guo BP; Zhao G; Han Q; Dai L; Mo YQ
    Front Med (Lausanne); 2022; 9():860798. PubMed ID: 35433730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Preliminary Study of Frequency and Clinical Relevance of Cytotoxic Peripheral CD4 and CD8 T Cells in Patients with Anti-MDA5 Positive Dermatomyositis.
    Jia F; Jiang S; Zhang J; Fu Q; Zhang X; Ye Y
    Rheumatol Immunol Res; 2022 Oct; 3(3):136-142. PubMed ID: 36788974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.